Butterfield D Allan, Kanski Jaroslaw
Department of Chemistry, Center of Membrane Sciences, and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40506, USA.
Peptides. 2002 Jul;23(7):1299-309. doi: 10.1016/s0196-9781(02)00066-9.
Amyloid beta-peptide 1-42 [Abeta(1-42)] is central to the pathogenesis of Alzheimer's disease (AD), and the AD brain is under intense oxidative stress. Our laboratory combined these two aspects of AD into the Abeta-associated free radical oxidative stress model for neurodegeneration in AD brain. Abeta(1-42) caused protein oxidation, lipid peroxidation, reactive oxygen species formation, and cell death in neuronal and synaptosomal systems, all of which could be inhibited by free radical antioxidants. Recent studies have been directed at discerning molecular mechanisms by which Abeta(1-42)-associated free radical oxidative stress and neurotoxicity arise. The single methionine located in residue 35 of Abeta(1-42) is critical for these properties. This review presents the evidence supporting the role of methionine in Abeta(1-42)-associated free radical oxidative stress and neurotoxicity. This work is of obvious relevance to AD and provides a coupling between the centrality of Abeta(1-42) in the pathogenesis of AD and the oxidative stress under which the AD brain exists.
淀粉样β肽1-42 [Aβ(1-42)] 是阿尔茨海默病(AD)发病机制的核心,并且AD大脑处于强烈的氧化应激状态。我们实验室将AD的这两个方面结合起来,建立了Aβ相关自由基氧化应激模型,用于研究AD大脑中的神经退行性变。Aβ(1-42) 在神经元和突触体系统中引起蛋白质氧化、脂质过氧化、活性氧生成和细胞死亡,所有这些都可被自由基抗氧化剂抑制。最近的研究致力于探究Aβ(1-42) 相关自由基氧化应激和神经毒性产生的分子机制。位于Aβ(1-42) 第35位残基的单个甲硫氨酸对于这些特性至关重要。本综述展示了支持甲硫氨酸在Aβ(1-42) 相关自由基氧化应激和神经毒性中作用的证据。这项工作与AD明显相关,并在Aβ(1-42) 在AD发病机制中的核心地位与AD大脑所存在的氧化应激之间建立了联系。
Biochim Biophys Acta. 2005-1-17
Biochim Biophys Acta. 2002-3-16
Biochim Biophys Acta. 2007-8
Int J Mol Sci. 2024-10-10
Antioxidants (Basel). 2024-5-7
Curr Top Med Chem. 2023-10-5
Theranostics. 2020-5-23
Metab Brain Dis. 2019-7-2